Bayesian Health Receives First-Ever FDA Clearance for Continuous AI Sepsis Monitoring

Bayesian Health Receives First-Ever FDA Clearance for Continuous AI Sepsis Monitoring

Continuous AI monitoring earns regulatory validation, marking a milestone for Bayesian's real-time clinical intelligence platform and the new standard of proactive care it delivers.

Bayesian Health Receives FDA Clearance for Continuous AI Sepsis Monitoring

Bayesian Health today announced that its sepsis flagging device has received FDA 510(k) clearance—the first continuous AI sepsis monitor ever to do so. Early sepsis detection is a core module within Bayesian’s real-time clinical intelligence platform, which continuously monitors every patient, surfaces those who need attention, and gives clinicians the tools to set the right actions in motion. The clearance, which builds on Bayesian’s prior FDA …

Bayesian Health secures first FDA clearance for AI-driven continuous sepsis monitor

Bayesian's AI-driven device is the first of its kind to get the FDA's clearance for early sepsis detection.The post Bayesian Health secures first FDA clearance for AI-driven continuous sepsis monitor appeared first on Medical Device Network.